Collaboration with Tohoku University researchers identifies a novel therapeutic target for ALS.
Awarded Innovation Award by Kanagawa Business Audition (KBA) 2019.
Jiksak listed in Forbes Japan’s January 2019 special feature “200 Superstar Entrepreneurs”
INNO-vation Program is an initiative by Japan’s Ministry of Internal Affairs and Communication to support cutting edge technology
Jiksak is a recipient of the first round of support from the Japan Patent Office’s IP Acceleration Program for Startups (IPAS)
Jiksak Bioengineering secures 170 million JPY from ANRI, OHARA Pharma, Essential Pharma, and MediFuture to commercialize the Nerve Organoid Chip and f
